Cantor Fitzgerald Reiterates Overweight on Merck & Co, Maintains $135 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Merck & Co (NYSE:MRK) and maintained a price target of $135.
February 14, 2024 | 4:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cantor Fitzgerald reaffirms an Overweight rating on Merck & Co, with a price target of $135.
The reiteration of an Overweight rating and a high price target by a reputable analyst like Louise Chen from Cantor Fitzgerald could instill confidence among investors and potentially lead to a positive short-term price movement for Merck & Co.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90